Skip to main content

Corbion: Q1 2024 Interim Management Statement

Written by Customer Service on . Posted in Public Companies.

Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes its results for the quarter ending 31 March 2024.

Key highlights first quarter of 2024

  • Organic growth core activities:
    • Sales: volume/mix +1.7%, price -4.5%
    • Adjusted EBITDA: +0.7%
    • Adjusted EBITDA margin 13.8% (+ 50bps versus last year)
  • Sales € 344.3 million; an organic decrease of -3.4%
  • Adjusted EBITDA € 47.2 million; an organic decrease of -1.2%
  • Positive Free Cash Flow € 7.5 million
  • Double digit growth in sales and Adjusted EBITDA in Health & Nutrition
  • TotalEnergies Corbion joint venture: sales € 31.6 million; an organic growth of 24.3%
  • Divestment of non-core US Emulsifier business completed on April 1st
  • Share buyback program of € 20.0 million and special cash dividend of € 0.10 per share
  • Confirmation of FY24 outlook
€ millionQ1 2024Q1 2023Total growthOrganic growth
Sales344.3359.6-4.3%-3.4%
Adjusted EBITDA47.248.4-2.5%-1.2%
     
Core activities    
Sales300.9312.5-3.7%-2.8%
Adjusted EBITDA41.441.6-0.5%0.7%

Commenting on today’s results, Olivier Rigaud, CEO, said:

“I am pleased to see positive volume/mix growth and organic Adjusted EBITDA growth in our core activities as well as a continuation of our positive free cash flow delivery. We made good progress in the implementation of our restructuring program including mothballing our plant in Peoria, US intended to increase free cash flow and margins going forward. Building on Corbion’s first-quarter performance, we are on-track to deliver in line with our full year guidance.

In Functional Ingredients & Solutions, we saw continued positive momentum in our Food segment leading to volume/mix growth in the first quarter in this segment. As previously indicated, the non-food segment is facing temporarily softness in some markets, including semiconductors. In line with our earlier guidance, pricing has been lower as a result of price reductions in some areas following input cost relaxation. In Health & Nutrition, we continue to see strong double digit growth in both sales and adjusted EBITDA mainly driven by the Nutrition segment (Omega-3 DHA within aquaculture and pet nutrition).

Upon the completion of the commissioning phase of our new circular lactic acid plant in Thailand, we have entered the start-up phase and expect production to gradually ramp up.

On April 1st, we completed the divestment of the non-core US Emulsifier business. As a result, we have decided on a share buyback program of € 20 million and a special cash dividend of € 0.10 per share in line with our capital allocation priorities, leaving sufficient bandwidth for investments to support continued growth”.

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.